Argus Reiterates Focus-List Buy On Celgene Following Q1 Results By: Benzinga via Benzinga May 18, 2016 at 09:24 AM EDT Celgene Corporation (NASDAQ: CELG) reported robust 1Q results. Argus’ David Toung maintained a Focus-List Buy rating for the ... Read More >> Related Stocks: Celgene Corp